Detalhe da pesquisa
1.
Mycobacterium tuberculosis gyrase inhibitors as a new class of antitubercular drugs.
Antimicrob Agents Chemother
; 59(4): 1868-75, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25583730
2.
Preclinical characterization of GSK2336805, a novel inhibitor of hepatitis C virus replication that selects for resistance in NS5A.
Antimicrob Agents Chemother
; 58(1): 38-47, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24126581
3.
In vitro characterization of GSK2485852, a novel hepatitis C virus polymerase inhibitor.
Antimicrob Agents Chemother
; 57(11): 5216-24, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23939896
4.
Impact of common epidermal growth factor receptor and HER2 variants on receptor activity and inhibition by lapatinib.
Cancer Res
; 68(2): 571-9, 2008 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18199554